Researchers design a new intracorneal inlay to correct presbyopia

February 7, 2018, Asociacion RUVID

Researchers at the Universitat Politècnica de València, University of Valencia, Instituto de Investigación Sanitaria La Fe and the companies AJL Ophthalmic SA and Aiken-Tecnología Ocular Preventiva SL have designed a new type of intracorneal inlay to correct presbyopia and farsightedness.

The design is based on a diffractive with micro-holes that permit the flow of nutrients in the corneal stroma. Also, this new type of prosthesis allows doctors to customize the treatment of presbyopia (far-sightedness). Unlike its commercial counterparts, due to its high-efficiency, the prosthesis can be implanted in both eyes without producing binocular vision. The design is easily adaptable to the shape of the intraocular lens and contact lens.

According to Juan Antonio Monsoriu, researcher at Politècnica de València, standard treatment for farsightedness has included bifocal and progressive contact lenses, multifocal intraocular lenses, etc. The most current alternatives include the use of intracorneal inlays. However, "these prostheses are limited because of the reduction of the retinal image quality produced by the diffractive light passing through the micro-holes necessary for the proper flow of nutrients," says Juan A. Monsoriu.

In order to reduce those undesired effects of light diffraction, the researchers have invented a solution: the redistribution of the lens micro-holes, which turns the diffraction produced by the holes into a beneficial factor. In addition, in this case it is possible to implant it in both eyes without producing binocular vision problems, which is not feasible with the inlays currently used.

"In our invention, the distribution of the micro-holes is concentrated in rings distributed inside a zone plate made for a specific area. In addition, this new lens presents a new versatile design, as it permits a variable density of holes in each area, depending on the relative intensity wanted between the different focuses generated by the lens for correcting ocular aberrations," says Waler D. Furlan, coordinator of the DiOG (Diffractive Optics Group) Research Group of the University of Valencia.

For intracorneal inlays in emmetropic eyes, this is safer than LASIK surgery, as the removal of the corneal tissue is not necessary. However, this technique is totally suitable for patients with presbyopia with some refractive error.

The main advantages of this technique include that it allows patients with presbyopia to clearly see near objects and also that can be customized depending on the visual needs of the patient: working distance, pupillary diameter, focus relative intensity, etc. It offers the possibility of being used in both eyes without creating binocular vision problems and it provides an extension of the depth of far focus of the eye and the near focus while guaranteeing an optimized range of clear vision for near and far objects.

Explore further: New help for that bane of middle-age: blurry close-up vision

More information: Walter D. Furlan et al. Diffractive corneal inlay for presbyopia, Journal of Biophotonics (2017). DOI: 10.1002/jbio.201600320

Related Stories

New help for that bane of middle-age: blurry close-up vision

February 28, 2017
Squinting while texting? Always losing your reading glasses? An eye implant that takes about 10 minutes to put in place is the newest in a list of surgical repairs for the blurry close-up vision that is a bane of middle age. ...

Myopia-related differences in eye structure may help in developing 'customized' intraocular lenses

December 28, 2015
The presence of myopia, or nearsightedness, significantly affects the muscles used in focusing the lens of the eye—a finding with important implications for the development of "accommodating" implanted intraocular lenses ...

Treatments may help people with aging eyes see up close without reading glasses

October 18, 2016
Researchers are testing cutting-edge treatments for people who want to see up close without reading glasses and finding promising results, according to studies presented this week at AAO 2016, the 120th annual meeting of ...

FDA approves eye implant to correct presbyopia in middle age

July 1, 2016
(HealthDay)—An implant that helps the aging eye focus on small print and nearby objects has been approved by the U.S. Food and Drug Administration.

Recommended for you

Glaucoma study finds brain fights to preserve vision

February 23, 2018
A team of researchers, led by David Calkins, Ph.D., vice chair and director of Research at the Vanderbilt Eye Institute, has made a breakthrough discovery in the field of glaucoma showing new hopes for treatments to preserve ...

In effort to treat rare blinding disease, researchers turn stem cells into blood vessels

February 13, 2018
People who inherit a mutated version of the ATF6 gene are born with a malformed or missing fovea, the eye region responsible for sharp, detailed vision. From birth, their vision is severely limited, and there is no cure. ...

Antioxidant therapy prevents devastating vision loss when added to standard-of-care on rare birth defect

February 5, 2018
A new study led by vision researchers at the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo and VA Western New York Healthcare System has demonstrated that the addition of widely available ...

Genetic basis for glaucoma uncovered

January 30, 2018
In two recent publications, Northwestern Medicine scientists and international collaborators discovered mutations that cause improper drainage and a buildup of ocular pressure leading to one form of congenital glaucoma, and ...

Study advances gene therapy for glaucoma

January 16, 2018
While testing genes to treat glaucoma by reducing pressure inside the eye, University of Wisconsin-Madison scientists stumbled onto a problem: They had trouble getting efficient gene delivery to the cells that act like drains ...

New study offers added hope for patients awaiting corneal transplants

January 9, 2018
New national research led by Jonathan Lass of Case Western Reserve University School of Medicine has found that corneal donor tissue can be safely stored for 11 days before transplantation surgery to correct eye problems ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.